Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Berk

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Connective Tissue Research|January 1, 1996
Regulation of type I collagen production by insulin and transforming growth factor-beta in human lung fibroblastsM Krupsky, A Fine, P P Kuang, et al.
Surgery|September 1, 1977
The role of adrenergic stimulation in the pathogenesis of pulmonary insufficiencyJ L Berk, J F Hagen, R K Tong, et al.
Medicine|April 20, 2000
Tracheobronchial amyloidosis. The Boston University experience from 1984 to 1999A O'Regan, H M Fenlon, J F Beamis, et al.
Annals of Surgery|October 1, 1973
Pulmonary insufficiency caused by epinephrineJ L Berk, J F Hagen, R Koo, et al.
Annals of Internal Medicine|May 1, 2001
Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal diseaseL M Dember, V Sanchorawala, D C Seldin, et al.
Bone Marrow Transplantation|December 10, 2013
Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvementS Girnius, D C Seldin, H K Meier-Ewert, et al.
Bone Marrow Transplantation|June 26, 2007
Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosisV Sanchorawala, D G Wright, K Quillen, et al.
Journal of the Neurological Sciences|July 12, 2014
Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trialsN Suanprasert, J L Berk, M D Benson, et al.
British Journal of Haematology|March 23, 1999
Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosisR L Comenzo, V Sanchorawala, C Fisher, et al.
Bone Marrow Transplantation|December 17, 2003
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trialV Sanchorawala, D G Wright, D C Seldin, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Connective Tissue Research|January 1, 1996
Regulation of type I collagen production by insulin and transforming growth factor-beta in human lung fibroblastsM Krupsky, A Fine, P P Kuang, et al.
Surgery|September 1, 1977
The role of adrenergic stimulation in the pathogenesis of pulmonary insufficiencyJ L Berk, J F Hagen, R K Tong, et al.
Medicine|April 20, 2000
Tracheobronchial amyloidosis. The Boston University experience from 1984 to 1999A O'Regan, H M Fenlon, J F Beamis, et al.
Annals of Surgery|October 1, 1973
Pulmonary insufficiency caused by epinephrineJ L Berk, J F Hagen, R Koo, et al.
Annals of Internal Medicine|May 1, 2001
Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal diseaseL M Dember, V Sanchorawala, D C Seldin, et al.
Bone Marrow Transplantation|December 10, 2013
Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvementS Girnius, D C Seldin, H K Meier-Ewert, et al.
Bone Marrow Transplantation|June 26, 2007
Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosisV Sanchorawala, D G Wright, K Quillen, et al.
Journal of the Neurological Sciences|July 12, 2014
Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trialsN Suanprasert, J L Berk, M D Benson, et al.
British Journal of Haematology|March 23, 1999
Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosisR L Comenzo, V Sanchorawala, C Fisher, et al.
Bone Marrow Transplantation|December 17, 2003
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trialV Sanchorawala, D G Wright, D C Seldin, et al.
Pageof 5